Back to Search
PAULA FRACASSO, MD
MD
Medical Oncology Physician
NPI: 1508895343Individual
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
0101242544(VA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
R2P12(MO)0101242544(VA)
Research & Publications (20)
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignancies.
PMID 18414864·Cancer Chemother Pharmacol·2009
3-trial
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
PMID 19318484·Clin Cancer Res·2009
3-trial
A phase I study of bexarotene and rosiglitazone in patients with refractory cancers.
PMID 18560232·Chemotherapy·2008
3-trial
Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies.
PMID 18534963·Ann Oncol·2008
3-trial
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer.
PMID 18509179·J Clin Oncol·2008
3-trial
A Phase I trial of weekly docetaxel and topotecan for solid tumors.
PMID 17896192·Acta Oncol·2008
3-trial
Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines.
PMID 18703609·J Nucl Med·2008
7-preclinical
A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab: pharmacokinetic and pharmacodynamic rationale for dosing.
PMID 17289894·Clin Cancer Res·2007
3-trial
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma.
PMID 17058289·Cancer·2006
3-trial
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
PMID 16712905·Gynecol Oncol·2006
3-trial
Sequence dependence of hematologic toxicity using carboplatin and topotecan for primary therapy of advanced epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.
PMID 16631245·Gynecol Oncol·2006
3-trial
A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.
PMID 16328044·Oncol Rep·2006
3-trial
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar.
PMID 15942626·Br J Cancer·2005
3-trial
A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
PMID 15887220·Cancer·2005
3-trial
Evaluation of epothilone B analog in advanced soft tissue sarcoma: a phase II study of the phase II consortium.
PMID 15860865·J Clin Oncol·2005
3-trial
Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.
PMID 15534095·Clin Cancer Res·2004
3-trial
Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia.
PMID 12921943·Leuk Res·2003
3-trial
Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.
PMID 12885801·J Clin Oncol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- HOSPITAL DRIVE, 4TH FLOOR
CHARLOTTESVILLE, VA 22908 - Phone
- (434) 924-9333
Quick Facts
- NPI
- 1508895343
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile